Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Earth Science Tech Inc ETST

Healthcare
Earth Science Tech, Inc. is a holding company in the compounding pharmaceuticals and telemedicine sectors, through its wholly owned subsidiaries, RxCompoundStore.com, LLC. (RxCompound), Peaks Curative, LLC. (Peaks), and Earth Science Foundation, Inc. (ESF). RxCompound is a complete compounding pharmacy. RxCompound is licensed to fulfill prescriptions in the states of Florida, New York, New... see more

Recent & Breaking News (OTCPK:ETST)

Earth Science Tech, Inc. Enters into a Joint Venture with Varsity Group, LLC. Under Its Wholly Owned Subsidiary KannaBidioid Inc.

GlobeNewswire July 6, 2017

Earth Science Tech, Inc. Receives a Price Target of $4.12 from Leading Independent Equity Research & Corporate Firm, SeeThruEquity

GlobeNewswire June 29, 2017

Earth Science Tech, Inc. Launches Earth Science Pharmaceutical & MSN-2 Medical Device Websites, Adds Michel Gauthier M.D. to the Advisory Board, and Reports Over 80% Profit Increase

GlobeNewswire June 19, 2017

Earth Science Tech, Inc. Announces New Wholly-Owned Subsidiary, KannBidioid Inc., to Manufacture & Distribute Vapes/E-Liquids & Gummy Edibles to Vape/Smoke Shops

GlobeNewswire June 13, 2017

Earth Science Tech, Inc. Presents at SeeThruEquity Microcap Investor’s 6th Annual Conference in New York June 1st

GlobeNewswire May 25, 2017

Earth Science Tech, Inc. Launches the First Ever Strawberry Orange Blossom CBD Oil, an Organic Chocolate CBD Edible Line, and It’s Pet CBD.

GlobeNewswire May 18, 2017

Earth Science Tech, Inc. Shares Achievements & Updates on it’s Cannabis CBD-Based Nutraceutical Patent Compounding

GlobeNewswire May 2, 2017

ETST Launches Cannabis Therapeutics Website, Shares Updates on their CBD-Based Nutraceutical Patents, & Hints on New Products Launching May 2017

GlobeNewswire April 20, 2017

Earth Science Tech, Inc. Targets Breast Cancer and Other Women's Health Issues in New Cannabis CBD-Based Pharmaceutical Drug Development Initiatives

GlobeNewswire April 11, 2017

Earth Science Tech, Inc. Expands Marketing Campaign to MassRoots (OTC: MSRT), Natural Awakenings Magazine, and Enhances Product Packaging

GlobeNewswire March 30, 2017

The Legal Cannabis Market Gaining Global Attention

PR Newswire March 29, 2017

Earth Science Tech, Inc. Announces Timeline Projection for its MSN-2 Medical Device, and Partnership Negotiations for its Cannabis CBD-Based Generic Drugs & Medical Device Distribution

GlobeNewswire March 27, 2017

ETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.

GlobeNewswire March 14, 2017

Earth Science Tech, Inc. Announces New Cannabis CBD-Based Sports Supplement with Forzagen, Karmavore Superfoods Sales Success, and Company Updates

GlobeNewswire March 9, 2017

Cannabinoid (CBD) Research and Development Remains Incredibly Strong in Spite of Federal Hesitation on Recreational Marijuana use

PR Newswire Europe Non Regulatory March 6, 2017

ETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.

GlobeNewswire March 6, 2017

Earth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory Board

GlobeNewswire February 28, 2017

FinancialBuzz.com: Cannabis Market Creating Jobs

PR Newswire February 23, 2017

Earth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent Studies

GlobeNewswire February 23, 2017

ETST and its wholly owned subsidiary, Cannabis Therapeutics, Signs Joint Venture with Smart Medicines GMP for the Development of its Cannabis Cannabinoid-Based Drugs & Nutraceuticals 

GlobeNewswire February 14, 2017